Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ocular Toxicity in Breast Cancer Management: Manual for The Oncologist.
Clin Breast Cancer. 2022 Jun;22(4):289-299. doi: 10.1016/j.clbc.2022.02.002. Epub 2022 Feb 7.
Clin Breast Cancer. 2022.
PMID: 35246390
Review.
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges.
Cerma K, Piacentini F, Moscetti L, Barbolini M, Canino F, Tornincasa A, Caggia F, Cerri S, Molinaro A, Dominici M, Omarini C.
Cerma K, et al. Among authors: tornincasa a.
Biomedicines. 2023 Jan 1;11(1):109. doi: 10.3390/biomedicines11010109.
Biomedicines. 2023.
PMID: 36672617
Free PMC article.
Review.
Item in Clipboard
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V.
Dieci MV, et al. Among authors: tornincasa a.
Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17.
Br J Cancer. 2023.
PMID: 36396818
Free PMC article.
Item in Clipboard
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V.
Dieci MV, et al. Among authors: tornincasa a.
Br J Cancer. 2023 Jan;128(2):398. doi: 10.1038/s41416-022-02087-9.
Br J Cancer. 2023.
PMID: 36460777
Free PMC article.
No abstract available.
Item in Clipboard
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients.
Canino F, Tornincasa A, Bettelli S, Manfredini S, Barbolini M, Moscetti L, Omarini C, Toss A, Tamburrano F, Antonelli G, Baglio F, Belluzzi L, Martinelli G, Natalizio S, Ponzoni O, Dominici M, Piacentini F.
Canino F, et al. Among authors: tornincasa a.
Int J Mol Sci. 2024 Feb 20;25(5):2490. doi: 10.3390/ijms25052490.
Int J Mol Sci. 2024.
PMID: 38473737
Free PMC article.
Item in Clipboard
Neoadjuvant Treatment for a cT4cN+ HER2+ Breast Cancer: Case Report of a Therapeutic Success.
Gunnellini M, Tornincasa A, Montedoro M, Caprodossi A, Prosperi E, Peverini M, Sarti AM, Aiuti S, Morini T.
Gunnellini M, et al. Among authors: tornincasa a.
Anticancer Res. 2024 Jun;44(6):2755-2758. doi: 10.21873/anticanres.17084.
Anticancer Res. 2024.
PMID: 38821608
Item in Clipboard
Cite
Cite